[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640085":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":27,"locations":36,"responsibleParty":55,"collaborators":57,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":10,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University Hospital, Bordeaux","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Control group",null,"patients who did not receive enteral or parenteral nutrition during neoadjuvant treatment.",{"label":13,"type":10,"description":14,"interventionNames":15},"Case group","patients who received enteral or parenteral nutrition during neoadjuvant treatment.",[16],"Dietary Supplement: Enteral or parenteral nutrition",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DIETARY_SUPPLEMENT","Enteral or parenteral nutrition","Patients who did not receive enteral or parenteral nutrition during neoadjuvant treatment.",[13],[24],{"name":25,"affiliation":5,"role":26},"Caroline GRONNIER, MD, PhD","PRINCIPAL_INVESTIGATOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Caroline GRONNIER, PhD, MD","CONTACT","+335-57-62-24-77","caroline.gronnier@chu-bordeaux.fr",{"name":34,"role":30,"phone":31,"phoneExt":10,"email":35},"Valérie AURILLAC","valerie.aurillac@chu-bordeaux.fr",[37],{"facility":38,"status":39,"city":40,"state":10,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Hopîtal du Haut Lévêque","RECRUITING","Pessac","33600","France","FR",{"type":45,"coordinates":46},"Point",[47,48],-0.6324,44.80565,{"lat":48,"lon":47},[51,54],{"name":52,"role":30,"phone":53,"phoneExt":10,"email":32},"Caroline GRONNIER","+ 33 5 57 65 60 05",{"name":25,"role":26,"phone":10,"phoneExt":10,"email":10},{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[58],{"name":59,"class":6},"French Eso-Gastric Tumors Working Group","100640085","evaluation-of-the-administration-of-artificial-nutrition-by-feeding-jejunostomy-during-neoadjuvant-treatment-on-postoperative-morbidity-in-the-context-of-esophageal-or-stomach-cancer-100640085",false,"NCT07584577","Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer","FREJENO","Inclusion Criteria:\n\n* Patient undergoing surgery for esophageal cancer\n* Malnourished patient at the time of management\n* Receiving neoadjuvant treatment\n\nExclusion Criteria:\n\n* Patient not malnourished at the time of management\n* Patient who did not receive neoadjuvant treatment","ALL","18 Years",{"count":70,"type":71},670,"ESTIMATED","OBSERVATIONAL","Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.",[75,76,77,78],"Esophageal Cancer","Surgery Indication","Malnourished","Neoadjuvant Treatment","2026-05-07",{"date":81,"type":82},"2026-05-13","ACTUAL",{"date":84,"type":71},"2026-11-01",{"date":86,"type":71},"2026-11-30",{"name":5,"class":6},1]